Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 31, 2022 - Issue 2
Submit an article Journal homepage
905
Views
2
CrossRef citations to date
0
Altmetric
Review

Current options and investigational drugs for the treatment of eosinophilic esophagitis

Sonsoles Tamarit-Sebastiana Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain;b Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), SpainORCID Iconhttps://orcid.org/0000-0001-5309-8310View further author information
ORCID Icon,
Francisco Miguel Ferrer-Solerb Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Spain;c Hospital Pharmacy, Hospital General de Tomelloso, SpainView further author information
&
Alfredo J Lucendoa Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain;b Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Spain;c Hospital Pharmacy, Hospital General de Tomelloso, Spain;d Instituto de Investigación Sanitaria Princesa (IIS-IP), Spain;e Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1183-1072View further author information
ORCID Icon
Pages 193-210 | Received 08 Nov 2021, Accepted 20 Jan 2022, Published online: 31 Jan 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alfredo J Lucendo & Javier Molina-Infante. (2022) Current treatment options and long-term outcomes in patients with eosinophilic esophagitis. Expert Review of Clinical Immunology 18:8, pages 859-872.
Read now
Alfredo J Lucendo. (2022) Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opinion on Pharmacotherapy 23:7, pages 827-840.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.